SCHEMBL265331

SCHEMBL265331

C[C@H]1CCC(=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5306053 1.00 CA1 (1.00)
SCHEMBL37255 1.00
SCHEMBL265674 1.00
SCHEMBL29465872 1.00
SCHEMBL28883290 0.97
Water SCHEMBL28652816 0.97
Methyl Alcohol SCHEMBL23272001 0.95
Cyclohexane SCHEMBL29120104 0.93 CA1 (0.86)
Benzene SCHEMBL28655502 0.93 CA1 (0.86)
Dimethylamine SCHEMBL4684858 0.93 CA1 (0.86)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 US claimed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 EP claimed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 WO claimed
JP-56065883-A None JP disclosed
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 US disclosed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 EP disclosed
US-12037354-B2 Cyclic pantetheine derivatives and uses thereof VECTIVBIO COMET AG (CH) 2024-07-16 US disclosed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 WO disclosed
CN-114057673-B Synthesis method of gamma-or delta-substituted alkyl chiral lactone 中国科学技术大学 2023-07-14 CN disclosed
US-9951163-B2 (Meth)acrylate compound, (meth)acrylic copolymer and photosensitive resin composition containing same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2018-04-24 US disclosed
WO-2017004283-A1 NOVEL GLUCAGON-LIKE PEPTIDE 1 MODULATOR AND USES THEREOF LIANG, CHI-MING (US) 2017-01-05 WO disclosed
US-20070043240-A1 Method for the synthesis of 4-hydroxyisoleucine and the derivatives thereof MIOSKOWSKI CHARLES 2007-02-22 US disclosed
WO-2006078724-A2 MACROCYCLIC ANALOGS FOR THE TREATMENT OF IMMUNOREGULATORY DISORDERS AND RESPIRATORY DISEASES ARRAY BIOPHARMA NC. (US) 2006-07-27 WO disclosed
US-20060160838-A1 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases ARRAY BIOPHARMA INC. 2006-07-20 US disclosed
US-20060030719-A1 Cis-3,5-disubstituted-dihydro-furan-2-ones and the preparation and use thereof E. I. DU PONT DE NEMOURS AND COMPANY 2006-02-09 US disclosed
WO-2005014565-A2 CIS-3,5-DISUBSTITUTED-DIHYDRO-FURAN-2-ONES AND THE PREPARATION AND USE THEREOF E.I. DUPONT DE NEMOURS AND COMPANY (US) 2005-02-17 WO disclosed
EP-0478147-B1 Process for producing optically active gamma-butyrolactone derivatives TAKASAGO PERFUMERY CO LTD (JP) 1996-11-06 EP disclosed
US-5420306-A Process for producing optically active γ-butyrolactone derivatives TAKASAGO INTERNATIONAL CORPORATION (JP) 1995-05-30 US disclosed
EP-0478147-A1 Process for producing optically active gamma-butyrolactone derivatives Takasago International Corporation (JP) 1992-04-01 EP disclosed
JP-S5665883-A ALPHA-BENZYLIDENE- S -GAMMA-METHYL-GAMMA-BUTYROLACTONE DERIVATIVE AND FUNGICIDE FOR AGRICULTURE AND GARDENING COMPRISING IT AS ACTIVE INGREDIENT SUMITOMO CHEM CO LTD 1981-06-03 JP disclosed